Contingent assessment of the COVID-19 vaccine

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorGarcía, Leidy Y.-
Autor(es): dc.creatorCerda, Arcadio A.-
Data de aceite: dc.date.accessioned2026-02-09T11:19:34Z-
Data de disponibilização: dc.date.available2026-02-09T11:19:34Z-
Data de envio: dc.date.issued2020-06-26-
Data de envio: dc.date.issued2020-06-26-
Data de envio: dc.date.issued2019-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/41577-
Fonte completa do material: dc.identifierhttps://www.sciencedirect.com/science/article/pii/S0264410X20308549-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1138492-
Descrição: dc.descriptionThe COVID-19 pandemic has not only had a negative impact on people’s health and life behavior, but also on economies around the world. At the same time, laboratories and institutions are working hard to obtain a COVID-19 vaccine, which we hope will be available soon. However, there has been no assessment of whether an individual and society value ​​a vaccine monetarily, and what factors determine this value. Therefore, the objective of this research was to estimate the individual’s willingness to pay (WTP) for a hypothetical COVID-19 vaccine and, at the same time, find the main factors that determine this valuation. For this, we used the contingent valuation approach, in its single and double-bounded dichotomous choice format, which was based on a hypothetical market for a vaccine. The sample used was obtained through an online survey of n = 566 individuals from Chile. The main results showed that the WTP depends on the preexistence of chronic disease (), knowledge of COVID-19 (), being sick with COVID-19 (), perception of government performance (), employment status (), income (), health care (), adaptation to quarantine with children at home ( and whether the person has recovered from COVID-19 (. According to our discrete choice model in double-bounded dichotomous format, it was concluded that the individuals’ WTP is US$184.72 (CI: 165.52-203.92; p < 0.01). This implies a social valuation of approximately US$2,232 million, corresponding to 1.09% of the GNP per capita.-
Idioma: dc.languageen-
Publicador: dc.publisherElsevier-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceVaccine-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-
Palavras-chave: dc.subjectVaccine-
Palavras-chave: dc.subjectHealth economics-
Palavras-chave: dc.subjectContingent valuation-
Título: dc.titleContingent assessment of the COVID-19 vaccine-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.